“May all be happy, may all be healed, may all be at peace and may no one ever suffer."
Adrenoleukodystrophy (ALD) is a rare genetic disorder that affects the nervous system and the adrenal glands. It is caused by the buildup of certain types of fatty acids in the brain and other tissues, which can lead to damage to the myelin sheath, the protective covering around nerve fibers.
There are several forms of ALD, including:
Symptoms of ALD can vary depending on the form and severity of the disorder, but may include:
ALD is caused by a genetic mutation that affects the production of a protein that helps break down certain fatty acids. It is inherited in an X-linked recessive pattern, which means that it primarily affects males and is passed from mothers to their sons.
There is currently no cure for ALD, but treatment options are available to manage symptoms and slow the progression of the disease. These may include medications to manage adrenal insufficiency, enzyme replacement therapy, and bone marrow transplantation.
It's important to seek medical attention if you or a loved one is experiencing symptoms that may be related to ALD. With early diagnosis and proper management, people with ALD can live longer and have a better quality of life.
Adrenoleukodystrophy has no cure. However, stem cell transplantation may stop the progression of ALD if done when neurological symptoms first appear. Doctors will focus on relieving your symptoms and slowing disease progression.
Treatment options may include:
In a recent clinical trial, boys with early-stage cerebral ALD were treated with gene therapy as an alternative to stem cell transplantation. Early results from gene therapy are promising. Disease progression stabilized in 88 percent of boys who participated in the trial. Additional research is necessary to assess long-term results and safety of gene therapy for cerebral ALD.